This content is from: Patents

EPO revokes Broad Institute’s CRISPR patent

The EPO has denied the Broad Institute of MIT and Harvard’s reliance on its US priority provisional application in revoking a CRISPR patent. The institute has already said it will appeal

Get Free Access to read more …

To read the full article, activate your free trial.

Get Free Access
  • Unlimited articles for one week
  • No commitments; no payment details required
  • Featuring IP strategy, copyright, patents, trademark and more!

Are you a Managing IP subscriber? Simply login here.

Related